2025年全球DNA診斷市場報告

預計未來幾年DNA診斷藥物市場將快速成長。到 2029 年，這一數字將成長至 386.4 億美元，複合年成長率為 10.8%。預測期內的成長歸因於癌症患病率的上升、對標準化診斷測試的需求的增加、遺傳疾病患病率的上升、對生物標記發現、罕見疾病和罕見疾病藥物的關注度的增加以及遠距遠端醫療和遠距測試的成長。預測期內的關鍵趨勢包括微生物組分析的整合、區塊鏈技術的整合、多組體學資料的整合、非侵入性測試、多體學的整合、可攜式和照護現場DNA 診斷設備的開發以及次世代定序儀(NGS)。

遺傳疾病發病率的不斷上升將在不久的將來推動 DNA 診斷市場的擴張。遺傳疾病的特徵是由於基因組異常而導致的健康問題，由於多種因素，包括診斷能力的提高、廣泛的基因檢測的可用性、環境影響以及人群中的親屬關係，遺傳疾病的發病率正在上升。總的來說，這些因素有助於提高對遺傳疾病的認知和識別。 DNA診斷透過分析遺傳物質，在準確識別遺傳疾病、促進早期診斷、制定個人化治療方法和明智的計劃生育決策方面發揮關鍵作用。例如，根據世界衛生組織（WHO）2023年2月的數據，先天性疾病每年導致全球約24萬新生兒死亡，另有17萬名1個月至5歲之間的兒童死亡。因此，遺傳疾病的盛行率不斷上升，推動了DNA診斷市場的成長。

DNA 診斷領域的主要企業正專注於開發創新產品，例如用於早期檢測各種癌症的液態切片測試。液態切片測試是一種微創診斷方法，用於識別和分析血液中存在的、源自腫瘤和其他細胞的循環性腫瘤細胞(CTC)、遊離 DNA (cfDNA) 和外泌體等生物標記。例如，2023 年 5 月，美國著名醫療診斷公司 Laboratory Corporation 宣布推出一項名為 LabCorp Plasma Focus 的新型液態切片測試。該測試旨在為確診進行性或轉移性固態腫瘤的患者確定標靶治療方案。 LabCorp Plasma Focus 利用基因定序技術來評估癌細胞脫落的循環遊離 DNA (cfDNA)。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球 DNA 診斷 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球DNA診斷市場：成長率分析
• 全球 DNA 診斷市場表現：規模與成長，2019-2024 年
• 全球 DNA 診斷市場預測：規模與成長，2024-2029 年，2034 年
• 全球 DNA 診斷總目標市場 (TAM)

第6章市場區隔

• 全球 DNA 診斷市場（按產品類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
• 裝置
• 試劑
• 軟體和服務
• 全球 DNA 診斷市場（按技術、性能和預測）2019-2024 年、2024-2029 年、2034 年
• 聚合酵素鏈鎖反應
• 微陣列
• 原位雜合技術
• 定序技術
• 質譜法
• 全球 DNA 診斷市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 腫瘤學
• 感染疾病治療
• 肌病變疾病的治療
• 臨床診斷確認
• 產前
• 胚胎著床前
• 其他用途
• 全球 DNA 診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 照護現場
• 診斷中心
• 自我檢測或非處方藥
• 全球 DNA 診斷市場，按儀器類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• DNA分析儀
• PCR儀（聚合酵素鏈鎖反應）
• 定序儀（次世代定序、桑格定序）
• 電泳系統
• 基因表現分析儀
• 微陣列系統
• 流式細胞儀
• 光強度
• 全球 DNA 診斷市場，按試劑類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
• PCR試劑
• DNA萃取試劑套件
• 定序試劑
• DNA檢測抗體
• 螢光染料和探針
• 核酸精製化學品
• DNA分析緩衝液
• 雜合反應和擴增試劑套件
• 全球 DNA 診斷市場軟體細分（按類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
• DNA資料分析軟體
• 生物資訊平台
• 用於定序資料的基因組學軟體
• 實驗室資訊管理系統（LIMS）
• 資料視覺化工具
• 基因突變分析軟體
• 基因組圖譜軟體
• 全球 DNA 診斷市場，按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
• 基因檢測服務
• DNA定序服務
• 生物資訊諮詢與分析
• 臨床診斷服務
• 遺傳諮詢服務
• 自訂DNA診斷服務
• 研發服務

第7章 區域和國家分析

• 全球 DNA 診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球 DNA 診斷市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• DNA診斷市場：競爭格局
• DNA診斷市場：公司簡介
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Becton, Dickinson and Company
• Laboratory Corporation
• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• Agilent Technologies
• Illumina Inc
• PerkinElmer Inc
• bioMerieux SA
• Beckman Coulter Inc
• Sysmex Corporation
• Bio-Rad Laboratories Inc
• QIAGEN NV
• Natera Inc
• Myriad Genetics Inc.
• BGI Genomics Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年 DNA 診斷市場：提供新機會的國家
• 2029 年 DNA 診斷市場：細分領域蘊含新機會
• 2029 年 DNA 診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

DNA diagnostics involves utilizing genetic testing techniques to examine DNA, RNA, and proteins for medical, forensic, or research purposes. These tests offer valuable insights into genetic predispositions, disease susceptibility, and ancestry, thereby revolutionizing the fields of medicine and genetics and providing effective tools for health management.

DNA diagnostic products encompass instruments, reagents, software, and services. Instruments are specialized equipment used for DNA sample analysis, employing technologies such as polymerase chain reaction, microarray, in-situ hybridization, sequencing, and mass spectrometry. These technologies find applications in diverse areas including oncology, infectious disease treatment, myogenic disorder treatment, clinical diagnostics, prenatal and pre-implantation testing. End users of DNA diagnostic products include point-of-care facilities, diagnostic centers, and individuals seeking self-testing or over-the-counter solutions.

The DNA diagnostics market research report is one of a series of new reports from The Business Research Company that provides DNA diagnostics market statistics, including DNA diagnostics industry global market size, regional shares, competitors with a DNA diagnostics market share, detailed DNA diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the DNA diagnostics industry. This DNA diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The DNA diagnostics market size has grown rapidly in recent years. It will grow from $23.1 billion in 2024 to $25.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.

The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $38.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).

The increasing incidence of genetic disorders is poised to drive the expansion of the DNA diagnostics market in the foreseeable future. Genetic disorders, characterized by health issues stemming from abnormalities in the genome, are on the rise due to several factors including enhanced diagnostic capabilities, broader genetic testing availability, environmental influences, and consanguinity within populations. These factors collectively contribute to a heightened awareness and identification of genetic disorders. DNA diagnostics plays a crucial role in precisely identifying genetic disorders through the analysis of genetic material, facilitating early diagnosis, tailored treatment approaches, and informed family planning decisions. For example, according to the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 neonatal deaths worldwide annually, with an additional 170,000 deaths occurring in children aged between 1 month and 5 years. Consequently, the escalating prevalence of genetic disorders serves as a key driver for the growth of the DNA diagnostics market.

Leading players in the DNA diagnostics sector are directing their efforts towards the development of innovative products, including liquid biopsy tests, designed to detect various types of cancer in their early stages. Liquid biopsy tests represent a minimally invasive diagnostic approach that identifies and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, present in the bloodstream and originating from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a prominent US-based healthcare diagnostics company, introduced a novel liquid biopsy test named LabCorp Plasma Focus. This test is designed to identify targeted therapies for patients diagnosed with advanced or metastatic solid tumors. Leveraging genetic sequencing technology, LabCorp Plasma Focus evaluates circulating cell-free DNA (cfDNA) released by tumor cells, enabling oncologists to personalize treatment strategies and enhance patient care through targeted therapy plans.

In November 2022, Myriad Genetics Inc., a leading US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for approximately $67.5 million. This acquisition broadens Myriad's portfolio in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC, the acquired company, specializes in developing prenatal and pediatric genomic tests, aligning with Myriad's commitment to expanding its presence and capabilities in key segments of genetic diagnostics.

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
• 2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry
• 3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications
• 4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)

Subsegments

• 1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers
• 2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits
• 3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software
• 4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Diagnostics Market Characteristics

3. DNA Diagnostics Market Trends And Strategies

4. DNA Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global DNA Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global DNA Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global DNA Diagnostics Market Growth Rate Analysis
• 5.4. Global DNA Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global DNA Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global DNA Diagnostics Total Addressable Market (TAM)

6. DNA Diagnostics Market Segmentation

• 6.1. Global DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents
• Software And Services
• 6.2. Global DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction
• Microarray
• In-situ Hybridization
• Sequencing Technology
• Mass Spectrometry
• 6.3. Global DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Infectious Diseases Treatment
• Myogenic Disorder Treatment
• Clinical Diagnostic Confirmation
• Prenatal
• Pre-Implantation
• Other Applications
• 6.4. Global DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point Of Care
• Diagnostic Centers
• Self-Testing Or Over-The-Counter (OTC)
• 6.5. Global DNA Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Analyzers
• PCR Machines (Polymerase Chain Reaction)
• Sequencers (Next-Generation Sequencing, Sanger Sequencing)
• Electrophoresis Systems
• Gene Expression Analyzers
• Microarray Systems
• Flow Cytometers
• Spectrophotometers
• 6.6. Global DNA Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Reagents
• DNA Extraction Kits
• Sequencing Reagents
• Antibodies For DNA Detection
• Fluorescent Dyes And Probes
• Chemicals For Nucleic Acid Purification
• Buffer Solutions For DNA Analysis
• Hybridization And Amplification Kits
• 6.7. Global DNA Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Data Analysis Software
• Bioinformatics Platforms
• Genomics Software For Sequencing Data
• Laboratory Information Management Systems (LIMS)
• Data Visualization Tools
• Genetic Variant Analysis Software
• Genome Mapping Software
• 6.8. Global DNA Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing Services
• DNA Sequencing Services
• Bioinformatics Consulting And Analysis
• Clinical Diagnostic Services
• Genetic Counseling Services
• Custom DNA Diagnostics Services
• Research And Development Services

7. DNA Diagnostics Market Regional And Country Analysis

• 7.1. Global DNA Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global DNA Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA Diagnostics Market

• 8.1. Asia-Pacific DNA Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA Diagnostics Market

• 9.1. China DNA Diagnostics Market Overview
• 9.2. China DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA Diagnostics Market

• 10.1. India DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA Diagnostics Market

• 11.1. Japan DNA Diagnostics Market Overview
• 11.2. Japan DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA Diagnostics Market

• 12.1. Australia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA Diagnostics Market

• 13.1. Indonesia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA Diagnostics Market

• 14.1. South Korea DNA Diagnostics Market Overview
• 14.2. South Korea DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA Diagnostics Market

• 15.1. Western Europe DNA Diagnostics Market Overview
• 15.2. Western Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA Diagnostics Market

• 16.1. UK DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA Diagnostics Market

• 17.1. Germany DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA Diagnostics Market

• 18.1. France DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA Diagnostics Market

• 19.1. Italy DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA Diagnostics Market

• 20.1. Spain DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA Diagnostics Market

• 21.1. Eastern Europe DNA Diagnostics Market Overview
• 21.2. Eastern Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA Diagnostics Market

• 22.1. Russia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA Diagnostics Market

• 23.1. North America DNA Diagnostics Market Overview
• 23.2. North America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA Diagnostics Market

• 24.1. USA DNA Diagnostics Market Overview
• 24.2. USA DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA Diagnostics Market

• 25.1. Canada DNA Diagnostics Market Overview
• 25.2. Canada DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA Diagnostics Market

• 26.1. South America DNA Diagnostics Market Overview
• 26.2. South America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA Diagnostics Market

• 27.1. Brazil DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA Diagnostics Market

• 28.1. Middle East DNA Diagnostics Market Overview
• 28.2. Middle East DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA Diagnostics Market

• 29.1. Africa DNA Diagnostics Market Overview
• 29.2. Africa DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. DNA Diagnostics Market Competitive Landscape
• 30.2. DNA Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. DNA Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. Laboratory Corporation
• 31.3. Quest Diagnostics Incorporated
• 31.4. Eurofins Scientific SE
• 31.5. Agilent Technologies
• 31.6. Illumina Inc
• 31.7. PerkinElmer Inc
• 31.8. bioMerieux SA
• 31.9. Beckman Coulter Inc
• 31.10. Sysmex Corporation
• 31.11. Bio-Rad Laboratories Inc
• 31.12. QIAGEN N.V.
• 31.13. Natera Inc
• 31.14. Myriad Genetics Inc.
• 31.15. BGI Genomics Co. Ltd.

32. Global DNA Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Diagnostics Market

34. Recent Developments In The DNA Diagnostics Market

35. DNA Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 DNA Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 DNA Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 DNA Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer